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Neurochemistry International 48 (2006) 453–458AbstractSeveral evidences suggest that glutamate may be involved in retinal neurodegeneration in diabetic retinopathy (DR). For that reason, we
investigated whether high glucose or diabetes affect the accumulation and the release of [3H]-D-aspartate, which was used as a marker of the
glutamate transmitter pool. The accumulation of [3H]-D-aspartate did not change in cultured retinal neural cells treated with high glucose (30 mM)
for 7 days. However, the release of [3H]-D-aspartate, evoked by 50 mM KCl, significantly increased in retinal cells exposed to high glucose.
Mannitol, which was used as an osmotic control, did not cause any significant changes in both accumulation and release of [3H]-D-aspartate. In the
retinas, 1 week after the onset of diabetes, both the accumulation and release of [3H]-D-aspartate were unchanged comparing to the retinas of age-
matched controls. However, after 4 weeks of diabetes, the accumulation of [3H]-D-aspartate in diabetic retinas decreased and the release of [3H]-D-
aspartate increased, compared to age-matched control retinas.
These results suggest that high glucose and diabetes increase the evoked release of D-aspartate in the retina, which may be correlated with the
hypothesis of glutamate-induced retinal neurodegeneration in DR.
# 2006 Elsevier Ltd. All rights reserved.
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blindness among adults in the western countries. This disease
has been considered a vascular disease, but recent evidences
clearly demonstrate that the neural components of the retina
may be also affected. Loss of color vision and contrast
sensitivity (Daley et al., 1987; Roy et al., 1986; Sokol et al.,
1985) and changes in electroretinograms (Sakai et al., 1995) are
early signs of neural retinal dysfunction in diabetic patients. In
addition, it was reported an increase in neuronal cell loss and
apoptosis in the retina, in diabetic experimental models and
humans with diabetes (Abu-El-Asrar et al., 2004; Barber et al.,
1998; Martin et al., 2004).
Glutamate is the main excitatory neurotransmitter in the
central nervous system, including the retina (Ozawa et al.,* Corresponding author. Tel.: +351 239 480 222; fax: +351 239 480 280.
E-mail address: fambrosio@ibili.uc.pt (A.F. Ambro´sio).
0197-0186/$ – see front matter # 2006 Elsevier Ltd. All rights reserved.
doi:10.1016/j.neuint.2005.10.0131998). However, excessive activation of ionotropic glutamate
receptors leads to cell death (Ambrosio et al., 2000; Chen
et al., 2001; Ferreira et al., 1998). In some retinal diseases,
such as glaucoma and retinitis pigmentosa, toxicity mediated
by excessive activation of glutamate receptors seems to play
an important role (Vorwerk et al., 1999; Wong, 1994).
Regarding DR, several lines of evidence indicate that
glutamate may be also involved in retinal degeneration. It
was shown that both the metabolism and the concentration of
glutamate in the retina are altered in short-term experimental
diabetes. Diabetic rat retinas are less able to convert
glutamate into glutamine (Kowluru et al., 2001; Lieth
et al., 1998). Also, the concentration of glutamate is
increased in the vitreous of patients with proliferative DR
(Ambati et al., 1997), suggesting that glutamate levels are
increased in the retina, possibly without de novo synthesis
of glutamate (Lieth et al., 2000). Moreover, the high-affinity
L-glutamate/L-aspartate transporter (GLAST) is impaired, in
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diabetic rats, probably due to the oxidation of the glutamate
transporter (Li and Puro, 2002).
Since the alterations in the extracellular levels of excitatory
amino acids in the retina can be due to changes in their
mechanisms of uptake and release, in this study, we
investigated the effect of high glucose concentration and
diabetes on the accumulation and release of [3H]-D-aspartate, in
cultured retinal neural cells and in rat retinas.
1. Experimental procedures
1.1. Materials
Fetal bovine serum was purchased from BioWhittaker (Walkersville, MD,
USA) and trypsin (USP grade) was purchased from Invitrogen Corporation
(Carlsbad, CA, USA). [3H]-D-aspartate was obtained from Amersham Bios-
ciences (Buckingshire, UK) and Universol scintillation cocktail was pur-
chased from ICN (Irvine, CA, USA). All other reagents were from Sigma
Chemical Co. (St. Louis, MO, USA) or from Merck KGaA (Darmstadt,
Germany).
1.2. Animals
The animals were treated in agreement with the Association for Research in
Vision and Ophthalmology (ARVO) statement for the use of animals in vision
and ophthalmic research.
Diabetes was induced with a single intraperitoneal injection of 65 mg/kg
streptozotocin (STZ; freshly dissolved in citrate buffer; pH 4.5) in 8 weeks-old
male Wistar rats, and was confirmed 2 days later by blood glucose levels
exceeding 250 mg/dl.
1.3. Primary cultures of rat retinal neural cells
Retinal cell cultures were obtained from the retinas of 3–5 days-old Wistar
rats. Briefly, rat pups were anesthetized by intraperitoneal injection of
ketamine (0.05 ml of a 100 mg/ml solution) before decapitation, and the
retinas were dissected under sterile conditions, using a light microscope, in
Ca2+- and Mg2+-free Hank’s balanced salt solution (in mM: 137 NaCl, 5.4
KCl, 0.45 KH2PO4, 0.34 Na2HPO4, 4 NaHCO3, 5 glucose; pH 7.4). The
retinas were digested with 0.1 % trypsin (w/v) for 15 min at 37 8C. After
dissociation, the cells were pelleted by centrifugation and resuspended in
Eagle’s minimum essential medium (MEM) supplemented with 26 mM
NaHCO3, 25 mM HEPES, 10% heat-inactivated fetal bovine serum, penicillin
(100 U/ml) and streptomycin (100 mg/ml). The cells were plated at a density
of 2.0  106 cells per cm2 on 24-well plates and 35 mm Petri dishes, coated
with poly-D-lysine (0.1 mg/ml), for [3H]-D-aspartate accumulation and
release experiments, respectively. The cells were maintained at 37 8C in a
humidified atmosphere of 5% CO2/air. After 2 days in culture, the cells were
incubated with 25 mM D-glucose (final concentration 30 mM) or with 25 mM
D-mannitol (plus 5 mM glucose), which was used as an osmotic control, and
maintained for further 7 days. The concentration of glucose in control
conditions was 5 mM.
1.4. [3H]-D-aspartate accumulation experiments
Cultured cells were rinsed twice with saline buffer (in mM: 132 NaCl, 4
KCl, 1.4 MgCl2, 1 CaCl2, 1.2 H3PO4, 6 glucose, 10 HEPES-Na; pH 7.4), and
then incubated with 40 nM D-aspartate and 1 mCi/ml [3H]-D-aspartate in saline
buffer, for 45 min, the time necessary to attain the maximal accumulation, at
37 8C. The accumulation of [3H]-D-aspartate was stopped by washing the cells
twice with cold (4 8C) saline buffer, and then the cells were lysed with 0.2 M
perchloric acid (PCA).
The retinas were rapidly dissected in cold phosphate-buffered saline (PBS;
in mM: 137 NaCl, 2.7 KCl, 10 Na2HPO4, 1.8 KH2PO4; pH 7.4) and rinsed twicein saline buffer (in mM: 118 NaCl, 4.7 KCl, 1.17 MgSO4, 2.5 CaCl2, 1.2
KH2PO4, 25 NaHCO3, 5.6 glucose; pH 7.4), previously oxygenated. The retinas
were then incubated with 40 nM D-aspartate and 2 mCi/ml [3H]-D-aspartate, in
oxygenated saline buffer, for 45 min, at 37 8C. The accumulation of [3H]-D-
aspartate was stopped by washing the retinas with cold (4 8C) saline buffer, and
then the retinas were homogenized in 2 M PCA.
In both cell cultures and retinas, the suspension was centrifuged at
10,000 rpm for 3 min, the supernatant was collected, and the radioactivity
was measured in a Packard 2000 Spectrometer provided with dpm correction,
using Universol scintillation cocktail.
The results are expressed as the percentage of the accumulated radioactivity
relatively to the total radioactivity present in extracellular medium at the
beginning of the experiment. In the experiments using intact retinas, the results
are expressed per retina, since previous experiments have shown that there are
no significant changes in terms of total amount of protein between the various
groups.
1.5. [3H]-D-aspartate release experiments
Cultured cells were rinsed in saline buffer (in mM: 132 NaCl, 4 KCl, 1.4
MgCl2, 1 CaCl2, 1.2 H3PO4, 6 glucose, 10 HEPES-Na; pH 7.4), and then
incubated in saline buffer supplemented with 40 nM D-aspartate and 1 mCi/ml
[3H]-D-aspartate, for 45 min, at 37 8C. After loading, the cells were washed
three times with saline buffer. The release of [3H]-D-aspartate in cultured cells
was measured using a perfusion system, as described previously (Drejer et al.,
1987), with some modifications (Santos et al., 1996). Briefly, the Petri dishes
were covered with a piece of nylon mesh (pore size of 100 mm), and were
placed on a holder slightly inclined (58). Using two peristaltic pumps, warmed
media (37 8C), with the desired composition, was delivered to the dishes with a
flow rate of 2 ml/min. Cultured cells were perfused with saline buffer for
15 min. After that period, the fractions were collected every minute with a
Gilson FC-204 fraction collector, for 10 min. The cells were stimulated with
50 mM KCl, for 1 min, in saline buffer (iso-osmotic substitution of NaCl by
KCl to maintain osmolarity). At the end of the experiment, the cell cultures
were perfused with 0.2 M HCl for 5 min to collect the remaining intracellular
[3H]-D-aspartate.
The retinas were rapidly dissected in cold PBS and then rinsed in cold saline
buffer (in mM: 118 NaCl, 4.7 KCl, 1.17 MgSO4, 2.5 CaCl2, 1.2 KH2PO4, 25
NaHCO3, 5.6 glucose; pH 7.4). The retinas were incubated with 40 nM D-
aspartate and 2 mCi/ml [3H]-D-aspartate in the same saline buffer, previously
oxygenated, for 45 min, at 37 8C, and then washed three times. The retinas were
placed in perfusion chambers, between two pieces of nylon mesh (pore size of
100 mm), and then perfused with saline buffer for 15 min. As previously
described for the cell cultures, the fractions were collected every minute and
the cells were stimulated for 1 min with 50 mM KCl. At the end of the
experiments, the retinas were perfused with 0.2 M PCA for 5 min. To better
digest the tissue and collect the residual intracellular [3H]-D-aspartate, 2 M PCA
was added to the retinas.
The radioactivity present in each fraction was measured in a Packard 2000
Spectrometer provided with dpm correction, using Universol scintillation
cocktail.
The results were expressed as the percentage of radioactivity present in each
collected fraction, relatively to the total amount of radioactivity present inside
the cells at that time point (fractional release; Figs. 3A, 4A and C); or as the
percentage of [3H]-D-aspartate released above basal levels after stimulation,
relatively to the total radioactivity accumulated in the cells (Figs. 3B, 4B and
D). Total intracellular radioactivity was calculated by adding the radioactivity
corresponding to each fraction to the intracellular radioactivity. In the experi-
ments using intact retinas, the results are expressed per retina, since previous
experiments have shown that there are no significant changes in terms of total
amount of protein between the various groups.
1.6. Statistical analysis
Results are presented as mean  S.E.M. Statistical significance was deter-
mined using one-way ANOVA, and differences between treatments were
evaluated using the Dunnet’s post-hoc test. Where indicated, statistical analysis
was performed using the two-tailed Student’s t-test.
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Fig. 2. Effect of diabetes on the accumulation of [3H]-D-aspartate in rat retinas.
One and four weeks diabetic rat retinas (white bars) and retinas from age-
matched control rats (black bars) were incubated with 40 nM D-aspartate and
[3H]-D-aspartate (2 mCi/ml) for 45 min, at 37 8C. The uptake process was
stopped by washing the retinas with ice-cold saline buffer. The retinas were
then homogenized in 2 M PCA and centrifuged, and the radioactivity was
measured in the supernatants. The results are presented as percentage of total
radioactivity present in the incubation buffer at the beginning of the experiment,
and are expressed as the mean  S.E.M., of at least six independent experi-
ments. ***p < 0.001 significantly different of control, t-tailed Student’s t-test.2. Results
2.1. Effect of high glucose and diabetes on
[3H]-D-aspartate accumulation
The effect of high glucose on the accumulation of [3H]-D-
aspartate was evaluated in cultured retinal cells. Control cells
(5 mM glucose), cells exposed to 30 mM glucose or to 25 mM
mannitol (plus 5 mM glucose), which was used as an osmotic
control, were incubated with [3H]-D-aspartate for 45 min, the
time necessary to attain the maximal uptake (data not shown).
The accumulation of [3H]-D-aspartate was similar in the three
conditions tested. In control cells, the accumulation of [3H]-D-
aspartate was 64.6  5.3% of the total radioactivity added to
the incubation medium at the beginning of the experiments, and
in cells exposed to high glucose or mannitol the accumulation
was 72.1  2.2% or 65.0  3.9% of the total radioactivity,
respectively (Fig. 1).
The accumulation of [3H]-D-aspartate was also evaluated in
whole retinas of control and diabetic rats (Fig. 2). In the retinas
of 1 week diabetic rats, the accumulation of [3H]-D-aspartate
(51.9  1.7% of the total radioactivity added to the incubation
medium) was similar to the accumulation of [3H]-D-aspartate
in the retinas of age-matched control rats (49.9  2.0% of the
total radioactivity). However, there was a significant decrease
in the accumulation of [3H]-D-aspartate in the retinas of 4
weeks diabetic rats (41.5  1.6% of the total radioactivity),
when compared to the retinas of age-matched controls
(50.1  0.8% of the total radioactivity). No significant
changes were observed between control retinas from both
groups (1 and 4 weeks of diabetes), indicating that the dif-
ferences observed between 1 and 4 weeks diabetic rat retinas
were not due to aging.Fig. 1. Effect of high glucose on the accumulation of [3H]-D-aspartate in
cultured retinal neural cells. Retinal cells were exposed to high glucose
(30 mM) or to mannitol (25 mM) for 7 days. Control cells (black bar), high
glucose-treated cells (white bar) and mannitol-treated cells (grey bar) were
incubated with 40 nM D-aspartate and [3H]-D-aspartate (1 mCi/ml) for 45 min,
at 37 8C. The uptake process was stopped by washing the cells with ice-cold
saline buffer. The cells were then homogenized in 0.2 M PCA and centrifuged,
and the radioactivity was measured in the supernatants. The results are
presented as percentage of total radioactivity added to each well at the
beginning of the experiment, and are expressed as the mean  S.E.M., of at
least five independent experiments performed in duplicate.
Fig. 3. Effect of high glucose on the release of [3H]-D-aspartate evoked by KCl
in retinal cultures. Cells were exposed to high glucose (30 mM) or to mannitol
(25 mM) for 7 days. Control cells (black bar), high glucose-treated cells (white
bar) and mannitol-treated cells (grey bar) were incubated with 40 nM D-
aspartate and [3H]-D-aspartate (1 mCi/ml) for 45 min, at 37 8C. After this
period, the cells were kept under continuous perfusion and stimulated with
50 mM KCl for 1 min. (A) Representative graph illustrating the time-course of
the efflux of [3H]-D-aspartate. Each point represents the percentage of radio-
activity present in each collected fraction, relatively to the total amount of
radioactivity present in the cells at that time point. (B) The results represent the
percentage of [3H]-D-aspartate released above basal levels, relatively to the total
radioactivity accumulated in the cells, and are expressed as mean  S.E.M., of
at least four independent experiments. *p < 0.05 significantly different of
control, one-way ANOVA followed by Dunnet’s post-hoc test.
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Fig. 4. Effect of diabetes on the release of [3H]-D-aspartate evoked by KCl in rat retinas. The experiments were performed with retinas from 1 week (A and B) and 4
weeks (C and D) diabetic rats (open circles and white bars) and with retinas from age-matched control rats (black squares and black bars). The retinas were incubated
with 40 nM D-aspartate and [3H]-D-aspartate (2 mCi/ml) for 45 min, at 37 8C. Retinas were then kept under continuous perfusion and stimulated with 50 mM KCl for
1 min. (A and C) Graphs illustrating the time-course of the efflux of [3H]-D-aspartate. Each point represents the percentage of radioactivity present in each collected
fraction, relatively to the total amount of radioactivity present in the retinas at that time point. The results are expressed as mean  S.E.M. of at least three independent
experiments. (B and D) Results represent the percentage of [3H]-D-aspartate released above basal levels upon depolarization, relatively to the total radioactivity
accumulated in the retinas, and are presented as mean  S.E.M., of at least three independent experiments. **p < 0.01 significantly different of control, t-tailed
Student’s t-test.2.2. Effect of high glucose and diabetes on
[3H]-D-aspartate release
In cultured retinal cells, membrane depolarization with
50 mM KCl (1 min stimulation), induced a transient increase in
[3H]-D-aspartate release, as can be observed in Fig. 3A. The
release of [3H]-D-aspartate above basal levels, after stimulation,
significantly increased in high glucose-treated cells, as
compared to control cells. In control cells, the release of
[3H]-D-aspartate evoked by KCl was 0.059  0.0058% of the
total radioactivity accumulated in the cells (Fig. 3B). In cells
exposed to high glucose, the release of [3H]-D-aspartate evoked
by KCl increased to 0.090  0.0094% of the total radioactivity,
corresponding to 152.5  15.9% of the control. The incubation
of retinal cells with mannitol did not affect the release of [3H]-
D-aspartate, which was similar to control (0.068  0.0011% of
the total radioactivity), indicating that the effect of high glucose
was not due to the increase in osmolarity.
As in retinal cell cultures, stimulation of intact retinas with
50 mM KCl, for 1 min, caused a transient increase in the release
of [3H]-D-aspartate (see Fig. 4A and C). The release of [3H]-D-
aspartate from 1 week diabetic retinas was similar to the release
from the retinas of age-matched control rats (Fig. 4A and B). In
control retinas, the release of [3H]-D-aspartate above basal
levels was 0.86  0.24% of the total radioactivity accumulated
in the retinas, and in 1 week diabetic retinas the release was
0.65  0.12% of the total radioactivity.For longer periods of diabetes (4 weeks), the release of [3H]-
D-aspartate from diabetic retinas significantly increased, as
compared to the retinas of age-matched controls (Fig. 4C and
D). In control retinas, the release of [3H]-D-aspartate evoked by
KCl was 0.59  0.08% of the total radioactivity, and in diabetic
rat retinas, the release of [3H]-D-aspartate significantly
increased to 1.81  0.47% of the total radioactivity, which
corresponds to 306.8  79.7% of the control. No significant
changes were observed between control retinas from both
groups (1 and 4 weeks of diabetes), indicating that the
differences observed on the release of [3H]-D-aspartate between
1 and 4 weeks diabetic rat retinas were not due to aging.
3. Discussion
In this study, we demonstrate, for the first time, that elevated
glucose and diabetes increase the evoked release of excitatory
amino acids from retinal neural cells.
Several evidences point to a role of glutamate in the
pathogenesis of DR (Ambati et al., 1997; Kowluru et al., 2001;
Lieth et al., 2000; Ng et al., 2004), and we hypothesized that
neurodegeneration observed in DR could be due, at least in part,
to changes in excitatory amino acids accumulation and/or
release. Therefore, we investigated the effect of both high
glucose and diabetes on the accumulation and release of [3H]-D-
aspartate in retinal cell cultures and in whole retinas,
respectively. Retinal cell cultures were exposed to high glucose
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pathogenic factor in the development of DR.
Since L-glutamate is rapidly metabolized inside the cells, we
used [3H]-D-aspartate, which is a non-metabolizing analogue
of glutamate, and mimics its behavior. It is transported by
glutamate transporters and is released upon cell depolarization
(Cousin et al., 1997; Pocock and Nicholls, 1998; Santos et al.,
1996).
The accumulation of [3H]-D-aspartate in control and high
glucose-treated cells was similar. Also, there were no
significant changes in the accumulation of [3H]-D-aspartate
in diabetic retinas, 1 week after the onset of diabetes. However,
the accumulation of [3H]-D-aspartate significantly decreased
after 4 weeks of diabetes, suggesting that the changes in the
uptake of excitatory amino acids in the retina do not occur very
early in diabetes. This result is in agreement with the work from
Li and Puro (Li and Puro, 2002), who reported a decrease in the
activity of glutamate transporters, in Mu¨ller cells isolated from
the retinas of 4 weeks STZ-induced diabetic rats, due to their
oxidation. Therefore, a decrease in excitatory amino acids
uptake would be expected. Furthermore, decreased glutamate
uptake was demonstrated in the brain of Goto-Kakizaki rats, a
model of non-insulin-dependent diabetes mellitus (Duarte
et al., 2000), but no changes on the expression levels of
glutamate transporters were observed in the brain of diabetic
animals (Coleman et al., 2004).
The decrease in the uptake of excitatory amino acids could
lead to a chronic increase in their levels in the extracellular
space and to an overactivation of ionotropic glutamate
receptors, which may explain the retinal neuronal dysfunction
and possibly neuronal apoptosis that occurs during diabetes.
However, it was recently reported that the uptake of glutamate
is increased in Mu¨ller cells isolated from STZ-induced diabetic
rat retinas (Ward et al., 2005). These observations are
contradictory to ours, but this discrepancy may be due to the
experimental approaches used. While we have measured the
accumulation of [3H]-D-aspartate in whole intact retinas, Ward
et al. determined the uptake of D-aspartate in retinal
cryosections, analyzing the immunoreactivity of D-aspartate
in the cell somata of Mu¨ller cells. These groups of findings
clearly indicate that diabetes elicits alterations in excitatory
amino acids transport in the retina, but additional experiments
are needed to establish a possible correlation with changes in
glutamate transport and cell dysfunction or cell death.
The most important finding in this work is that the evoked
release of [3H]-D-aspartate increased in high glucose-treated
cells and in diabetic rat retinas (4 weeks of diabetes). These
changes were not due to the increase in osmolarity, since
mannitol, which was used as osmotic control, did not cause any
significant changes. These results may be correlated with
previous findings showing that the concentration of glutamate is
elevated in the retina in the early course of experimental
diabetes (Kowluru et al., 2001; Lieth et al., 1998) and the
concentration of glutamate is increased in the vitreous of
diabetic patients (Ambati et al., 1997), which may be, at least in
part, due to an increase in glutamate release. In addition,
glutamine synthetase, the enzyme that converts glutamate intoglutamine, appears to be downregulated in diabetic rat retinas
(Lieth et al., 2000), resulting in an increase in the concentration
of glutamate that can be released through the reversal of the
membrane transporters.
Using the same cell culture model, we have observed that the
[Ca2+]i changes evoked by high concentrations of KCl were
significantly higher in high glucose-treated cells than in control
cells (unpublished observations). This elevation in [Ca2+]i
could explain the increased release of [3H]-D-aspartate in retinal
cells cultured in high glucose concentration. The increase in
glutamate release upon depolarization might be responsible, at
least partially, for increased cell death observed in retinal
neurons. Particularly, ganglion cells, which are known to be
more susceptible to diabetes (Martin et al., 2004), are enriched
in ionotropic glutamate receptors, mostly N-methyl-D-aspartate
(NMDA) receptors, and overactivation of these receptors may
trigger cell apoptosis.
In conclusion, this work shows for the first time, that
hyperglycemic conditions increase the release of aspartate in
retinal neural cell cultures and in diabetic rat retinas. Thus, this
work supports the hypothesis that glutamate may be involved in
the pathogenesis of DR. Hyperglycemia may affect the
mechanisms of glutamate release, leading to glutamate excito-
toxicity, and ultimately to neuronal cell dysfunction and death.
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